Skip to content
Home/Companies/MedTech/Hemovent

Hemovent

MedTech·Germany·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns Hemovent?

Hemovent was owned by NRW.BANK through NRW.Venture (2006 vintage) from 2016 to 2021, exited via Trade Sale.

Hand-verified · updated 2026-08-10

NRW.BANK
Investor
NRW.BANK
NRW.Venture · 2006 · VC

Key facts

HQGermany
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MicroPort Scientific
MOIC
–
Exit Year
2021

More from NRW.Venture

Other portfolio companies in the same fund.

JUPUS
Jupus
Active
LegalTechGermany· 2026
clockin
clockin
Active
SaaSGermany· 2025
Disco Pharmaceuticals
Active
BiotechGermany· 2025
eeden
Active
ClimateTechGermany· 2025
iDEL Therapeutics
Active
BiotechGermany· 2025
Lidrotec
Active
Deep TechGermany· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue